Neoadjuvant Triple Therapy for Resectable HCC
NCT06569498
·
clinicaltrials.gov ↗
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Resectable Hepatocellular Carcinoma
Sponsor
Fujian Provincial Hospital